Inventiva (IVA) Receivables - Net (2018 - 2025)
Inventiva's (IVA) quarterly Receivables - Net came in at $2.3 million in Q4 2025, up 313.57% year-on-year from $567424.2 in Q4 2024, and down 99.98% quarter-over-quarter from $12.2 billion in Q2 2025.
Inventiva (IVA) Receivables - Net (2018 - 2025) Analysis & Trends
Inventiva's Receivables - Net history runs 8 years deep, the most recent figure standing at $2.3 million for Q4 2025.
- On a quarterly basis, Receivables - Net rose 313.57% year-over-year to $2.3 million in Q4 2025; TTM through Dec 2025 was $2.3 million, a 313.57% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 313.57% from the prior year.
- Receivables - Net slipped to $2.3 million in Q4 2025 per IVA's latest filing, from $12.2 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $12.2 billion in Q2 2025 and bottomed at $1206.2 in Q1 2021.
- The 5-year median for Receivables - Net is $2.4 million (2023), against an average of $1.2 billion.
- Across the five-year window, Receivables - Net sank 86.15% in 2024 and jumped 297101.78% in 2025, its largest moves.
- Year by year, Receivables - Net stood at $4.6 million in 2021, then slumped by 76.68% to $1.1 million in 2022, then surged by 283.87% to $4.1 million in 2023, then slumped by 86.15% to $567424.2 in 2024, then surged by 313.57% to $2.3 million in 2025.
- Per Business Quant, the three latest IVA Receivables - Net figures stand at $2.3 million (Q4 2025), $12.2 billion (Q2 2025), and $567424.2 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.35 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Jun 30, 2025 | 12.18 Bn |
| Jun 30, 2025 | 12.18 Bn |
| Dec 31, 2024 | 567,424.16 |
| Dec 31, 2024 | 567,424.16 |
| Jun 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Jun 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 2.42 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Jun 30, 2021 | 8,429.90 |
| Jun 30, 2021 | 8,429.90 |
| Mar 31, 2021 | 1,206.24 |
| Mar 31, 2021 | 1,206.24 |